Effective Treatment of Human Lung Cancer by Targeting Tissue Factor with a Factor VII-Targeted Photodynamic Therapy

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|11|9|1069-1081

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.11, Iss.9, 2011-11, pp. : 1069-1081

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cancer Therapy By Targeting Hypoxia-Inducible Factor-1

By  

Current Cancer Drug Targets, Vol. 10, Iss. 7, 2010-11 ,pp. : 782-796

Bentham Science Publishers

Access to resources Recommend Favorite

Gefitinib is an effective treatment for patients with non-small-cell lung cancer (NSCLC) and mutations in the epidermal growth factor receptor

By  

Inpharma, Vol. 1, Iss. 1547, 2006-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Vascular Endothelial Growth Factor-Targeted Therapy for the Treatment of Renal Cell Carcinoma

By Escudier Bernard   Albiges Laurence  

Drugs, Vol. 71, Iss. 9, 2011-06 ,pp. : 1179-1191

Adis International

Access to resources Recommend Favorite

Targeting fibroblast-growth-factor-receptor-dependent signaling for cancer therapy

By Heinzle Christine   Sutterlüüty Hedwig   Grusch Michael   Grasl-Kraupp Bettina   Berger Walter   Marian Brigitte  

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 7, 2011-07 ,pp. : 829-846

Informa Healthcare

Access to resources Recommend Favorite

ZD1839: targeting the epidermal growth factor receptor in cancer therapy

By Herbst Roy S  

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 6, 2002-06 ,pp. : 837-849

Informa Healthcare

Access to resources Recommend Favorite